These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7985934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients.
    Hughes RA, Hadden RD, Rees JH, Swan AV.
    Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rational therapy of Guillain-Barré syndrome.
    Raphael JC, Chevret S.
    Lancet; 1998 Mar 07; 351(9104):753. PubMed ID: 9504542
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T, Nakagawa H, Uchiyama F, Fukuyama J.
    Rinsho Shinkeigaku; 1993 Jun 07; 33(6):660-2. PubMed ID: 8403689
    [Abstract] [Full Text] [Related]

  • 8. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
    van der Meché FG.
    J Neurol Neurosurg Psychiatry; 1994 Nov 07; 57 Suppl(Suppl):33-4. PubMed ID: 7964849
    [No Abstract] [Full Text] [Related]

  • 9. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M, Olivier J, Vivant JF.
    Rev Neurol (Paris); 1992 Nov 07; 148(11):706-8. PubMed ID: 1303562
    [Abstract] [Full Text] [Related]

  • 10. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N, Uysal S, Cetinkaya F, Işlek I, Kalayci AG.
    Scand J Infect Dis; 1995 Nov 07; 27(3):241-3. PubMed ID: 8539548
    [Abstract] [Full Text] [Related]

  • 11. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC, Annane D, Chevret S, Chillet P, Gajdos P.
    Presse Med; 1996 Oct 19; 25(31):1516-22. PubMed ID: 8958883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Guillain-Barré disease: a current treatment method using immunoglobulins].
    Kleyweg RP, van der Meché FG.
    Ned Tijdschr Geneeskd; 1992 Oct 03; 136(40):1956-60. PubMed ID: 1328903
    [No Abstract] [Full Text] [Related]

  • 14. Changing views of Guillain-Barré syndrome.
    Asbury AK, McKhann GM.
    Ann Neurol; 1997 Mar 03; 41(3):287-8. PubMed ID: 9066348
    [No Abstract] [Full Text] [Related]

  • 15. [Guillain-Barré syndrome and plasma exchange].
    Raphael JC, Elkharrat D, Chevret S, Vercken JB, Chastang C, Gajdos P.
    Ann Med Interne (Paris); 1990 Mar 03; 141(7):593-6. PubMed ID: 2085236
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun 03; 35(6):749-52. PubMed ID: 8210234
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV.
    Ann Neurol; 1998 Nov 03; 44(5):780-8. PubMed ID: 9818934
    [Abstract] [Full Text] [Related]

  • 18. Guillian-Barre syndrome: issues in etiology and management.
    Garg RK.
    Indian Pediatr; 1997 Jan 03; 34(1):74-7. PubMed ID: 9251289
    [No Abstract] [Full Text] [Related]

  • 19. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome.
    McGhee B, Jarjour IT.
    Am J Hosp Pharm; 1994 Jan 01; 51(1):97-9. PubMed ID: 8135270
    [No Abstract] [Full Text] [Related]

  • 20. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA, Bogousslavsky J, Regli F.
    Rev Neurol (Paris); 1991 Jan 01; 147(8-9):573-6. PubMed ID: 1962066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.